Cyproterone Acetate
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB04839 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | migraine disorder | KG + DL |
| 2 | migraine with brainstem aura | KG + DL |
| 3 | Prinzmetal angina | KG + DL |
| 4 | antithrombin deficiency type 2 | KG + DL |
| 5 | heparin cofactor 2 deficiency | KG + DL |
| 6 | factor 5 excess with spontaneous thrombosis | KG + DL |
| 7 | migraine with or without aura, susceptibility to | KG + DL |
| 8 | amenorrhea (disease) | KG + DL |
| 9 | breast fibrocystic disease | KG + DL |
| 10 | thrombophilia | KG + DL |
| 11 | leprosy | KG + DL |
| 12 | rheumatoid arthritis | KG + DL |
| 13 | female breast carcinoma | KG + DL |
| 14 | atrophoderma vermiculata | KG + DL |
| 15 | benign mammary dysplasia | KG + DL |
| 16 | apocrine adenosis of breast | KG + DL |
| 17 | blunt duct adenosis of breast | KG + DL |
| 18 | pulmonary hypertension | KG + DL |
| 19 | kyphoscoliotic heart disease | KG + DL |
| 20 | ulerythema ophryogenesis | KG + DL |
| 21 | lactation disease | KG + DL |
| 22 | oral candidiasis | KG + DL |
| 23 | fat necrosis of breast | KG + DL |
| 24 | breast abscess | KG + DL |
| 25 | hyperthyroidism | KG + DL |
| 26 | gout | KG + DL |
| 27 | breast adenosis | KG + DL |
| 28 | brachydactyly-syndactyly syndrome | KG + DL |
| 29 | tendinitis | KG + DL |
| 30 | resistance to thyroid hormone due to a mutation in thyroid hormone receptor beta | KG + DL |
| 31 | colobomatous microphthalmia-rhizomelic dysplasia syndrome | KG + DL |
| 32 | hemoglobinopathy | KG + DL |
| 33 | commissural lip fistula | KG + DL |
| 34 | osteoradionecrosis of the mandible | KG + DL |
| 35 | fibromyalgia | KG + DL |
| 36 | oral leukoedema | KG + DL |
| 37 | burning mouth syndrome | KG + DL |
| 38 | idiopathic granulomatous myositis | KG + DL |
| 39 | myositis fibrosa | KG + DL |
| 40 | obsolete susceptibility to ischemic stroke | KG + DL |
| 41 | peripheral vascular disease | KG + DL |
| 42 | hypoalphalipoproteinemia | KG + DL |
| 43 | exostosis | KG + DL |
| 44 | partial deletion of the short arm of chromosome 16 | KG + DL |
| 45 | beta-thalassemia with other manifestations | KG + DL |
| 46 | pyropoikilocytosis, hereditary | KG + DL |
| 47 | dermatitis herpetiformis | KG + DL |
| 48 | hemolytic anemia due to glucophosphate isomerase deficiency | KG + DL |
| 49 | homozygous familial hypercholesterolemia | KG + DL |
| 50 | peripheral arterial disease | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.